• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISEENF
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Infarction, Cerebral (1771)
Event Type  Injury  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, weight, race, ethnicity, and medical history were not provided.Date of event: the date of the event/study is not known.The product catalog and lot numbers are not available / not reported.The expiration date of the device is not known.Information such as initial reporter facility name, address, city, state, name, phone and email address are not available / reported.The device manufacture date is not known as the product lot number of the device is not available / not reported.[conclusion]: it was reported through the database research activities, the real world comparison of outcomes among patients with unruptured intracranial aneurysm (uia) undergoing endovascular treatment using the enterprise stent versus neuroform or low-profile visualized intraluminal support (lvis) stent, there were 26 who were considered to have ischemic complication if they had the relevant international classification of diseases (icd)-9/10 codes listed during the admission period for aphasia, hemiplegia or paraplegia, or cerebral artery occlusion.No other information is available.Based on complaint information, the device was not available to be returned for analysis.The device lot number was not available.The device history record (dhr) review could not be performed without the lot number.Product analysis cannot be conducted as the product was not returned for analysis.In addition, there was no report of malfunction associated with the device.As such, the investigation will be closed.With very limited information, the cause of the ischemic complication in the 26 patients is not known.There was no information on patient medical history, and no information on the device and its performance during use in the study procedure.The device catalog and lot numbers are not known; therefore, the determination of possible device-related causes cannot be determined through device analysis or through device history record review.The exact cause of the event could not be conclusively determined.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective/preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This is one of four products involved with the reported complaint.The associated manufacturer report numbers are: 1226348-2019-01040, 1226348-2019-01041, 1226348-2019-01042, and 1226348-2019-01043.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
 
Event Description
It was reported through the database research activities, the real world comparison of outcomes among patients with unruptured intracranial aneurysm (uia) undergoing endovascular treatment using the enterprise stent versus neuroform or low-profile visualized intraluminal support (lvis) stent, there were 26 who were considered to have ischemic complication if they had the relevant international classification of diseases (icd)-9/10 codes listed during the admission period for aphasia, hemiplegia or paraplegia, or cerebral artery occlusion.No other information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key9506254
MDR Text Key188804679
Report Number1226348-2019-01041
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial
Report Date 11/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISEENF
Was Device Available for Evaluation? No
Date Manufacturer Received11/22/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-